Product Description
Overall, the global dental bone graft substitute market was valued at over $929 million in 2023. This is expected to increase over the forecast period at a CAGR of 5.5% to reach nearly $1.35 billion.
The full report suite on the global market for dental bone graft substitutes (DBGSs) includes segments for allografts, xenografts and synthetic DBGS products.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Dental Bone Graft Substitute Market Insights 
Global Dental Bone Graft Substitute Market Share Insights 
- In 2023, Geistlich led the global DBGS market, dominating the xenograft segment with its Bio-Oss® bovine xenograft product line, considered the gold standard worldwide. The 2020 expansion of Bio-Oss® Collagen to include a 50 mg size for narrow defect procedures bolstered its market presence. Geistlich’s specialization in bone, cartilage, and tissue regeneration drives its continued growth and innovation.
- ZimVie was the second-leading competitor, with its RegenerOss® allografts and Ingenios® synthetics. The company’s success largely stemmed from its Puros® mineralized allograft product line, offering a variety of options.
- BioHorizons secured a leading position with strong sales of its allograft products, including MinerOss®, Grafton® DBM, and LADDEC®, developed by Osteotech. The MinerOss® line includes cortical, cancellous, and mixed versions.
Market Segmentation Summary
- Dental Bone Graft Substitutes Membranes – Includes:
- By Type: Allograft, Xenograft, Synthetic
Global Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2020 |
Historical Data | 2020-2022 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |